Assessment of the Effectiveness of an Integrative Therapy for Cannabis Misuse in Adolescents (TIMCA)
Cannabis Use Disorder
About this trial
This is an interventional treatment trial for Cannabis Use Disorder focused on measuring Randomized Controlled Trial, Cannabis Use Disorder, Adolescents, Young adults, Motivational Interviewing, Cognitive and Behavioral Therapy, Attachment-based Intervention
Eligibility Criteria
Inclusion Criteria: Aged 14 to 19 years 11 months 29 (or 30) days at the time of the inclusion visit Consulting as an outpatient center: Fulfilling the criteria for Cannabis Use Disorder (CUD) according to DSM 5 criteria (mild, moderate or severe) Fluent in oral and written French Benefiting from a social security plan Having signed their consent to participate (and their legal representative if applicable). Exclusion Criteria: With an acute psychiatric disorder and/or a psychotropic treatment (a characterized depressive episode, a bipolar disorder, a psychotic disorder) With a substance use disorder other than cannabis and tobacco, Already engaged in another form of therapy Pregnant women at the time of inclusion Participants of age subject to a legal protection measure or unable to express their consent
Sites / Locations
- GHU Paris Psychiatrie & NeurosciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
TIMCA
Treatment as Usual
The intervention will combine elements of motivational interviewing, cognitive and behavioral therapy and an attachment-based intervention. Sessions with both the adolescent and his parents are planned.
The comparator, an active control, will be Treatment As Usual" (TAU) group, i.e., the therapy usually practiced in the services. Given the multiplicity of investigating centers and the different treatments offered according to the patient's problems, it seems difficult to choose a single reference treatment for the control arm. Each investigating center undertakes to adopt the treatment that seems most effective and appropriate for each patient